1,088 results

Filter

Focus on patient safety - "Neuroleptic medication. Vigilance is best practice"

Tool to improve professional practice - Posted on 3/11/2022

Download document

Add to my selection
Focus on patient safety - "Curare storage : Not so uncommon mistakes"

Tool to improve professional practice - Posted on 13/5/2022

Download document

Add to my selection
Focus on patient safety - "Medicinal product dose calculation. The rule of three must remain the rule."

Tool to improve professional practice - Posted on 17/1/2022

Download document

Add to my selection
Focus on patient safety - "Medical devices. Using them well... to prevent the worst."

Tool to improve professional practice - Posted on 19/11/2021

Download document

Add to my selection
Purulent acute otitis media in adults

Practice guidelines - Posted on 27/8/2021 - Mis à jour le 27/8/2021

Add to my selection
Purulent acute otitis media in children over 3 months

Practice guidelines - Posted on 27/8/2021 - Mis à jour le 27/8/2021

Add to my selection
Acute nasopharyngitis and acute strep throat in children

Practice guidelines - Posted on 27/8/2021 - Mis à jour le 27/8/2021

Add to my selection
Acute nasopharyngitis and acute strep throat in adults

Practice guidelines - Posted on 27/8/2021 - Mis à jour le 27/8/2021

Add to my selection
Adult sinusitis

Practice guidelines - Posted on 27/8/2021 - Mis à jour le 27/8/2021

Add to my selection
Paediatric sinusitis

Practice guidelines - Posted on 27/8/2021 - Mis à jour le 27/8/2021

Add to my selection
See 28 result in Practice Guidelines and Other Guides

YESCARTA (axicabtagene ciloleucel), CAR T anti-CD19

Medicine - Posted on 26/1/2023

Add to my selection
ENBREL (etanercept)

Medicine - Posted on 26/1/2023

Add to my selection
TECENTRIQ

Medicine - Posted on 20/1/2023

Add to my selection
KEYTRUDA

Medicine - Posted on 20/1/2023

Add to my selection
VEKLURY

Medicine - Posted on 13/1/2023

Add to my selection
XELJANZ

Medicine - Posted on 12/1/2023

Add to my selection
KISQALI

Medicine - Posted on 12/1/2023

Add to my selection
RINVOQ

Medicine - Posted on 12/1/2023

Add to my selection
HUMIRA

Medicine - Posted on 9/1/2023

Add to my selection
BRIVIACT (brivaracétam)

Medicine - Posted on 9/1/2023

Add to my selection
See 1055 result in Drugs, devices and medical acts

Early access authorisation : a positive initial report and refined assessment methods

Press release - Posted on 20/5/2022

Add to my selection
Early access to medicinal products

Web page - Posted on 1/7/2021 - Mis à jour le 20/5/2022

Add to my selection
The HAS medication action plan: a first positive assessment is drawn

Press release - Posted on 19/6/2020

Add to my selection
HAS unveils its action plan for innovative medicines

Press release - Posted on 27/1/2020

Add to my selection
Homeopathic medicines : insufficient therapeutic efficacy for reimbursement

Press release - Posted on 28/6/2019 - Mis à jour le 13/2/2020

Add to my selection
See 5 result in Articles and news

My account

You do not have a saved search

No element in selection

1,088 results

Practice guidelines and other guides - 28 results

Focus on patient safety - "Neuroleptic medication. Vigilance is best practice"

Focus on patient safety - "Curare storage : Not so uncommon mistakes"

Focus on patient safety - "Medicinal product dose calculation. The rule of three must remain the rule."

Focus on patient safety - "Medical devices. Using them well... to prevent the worst."

Purulent acute otitis media in adults

Purulent acute otitis media in children over 3 months

Acute nasopharyngitis and acute strep throat in children

Acute nasopharyngitis and acute strep throat in adults

Adult sinusitis

Paediatric sinusitis

Drugs, devices and medical acts - 1,055 results

YESCARTA (axicabtagene ciloleucel), CAR T anti-CD19

ENBREL (etanercept)

TECENTRIQ

KEYTRUDA

VEKLURY

XELJANZ

KISQALI

RINVOQ

HUMIRA

BRIVIACT (brivaracétam)

Articles and news - 5 results

Early access authorisation : a positive initial report and refined assessment methods

Early access to medicinal products

The HAS medication action plan: a first positive assessment is drawn

HAS unveils its action plan for innovative medicines

Homeopathic medicines : insufficient therapeutic efficacy for reimbursement

Follow us :